Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.12 | 0.7 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |